In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
Thoracic surgeon Valerie Rusch
Q&A
8 Questions with Valerie Rusch: Lung Cancer Surgeon Reflects on Advances and Providing Excellent Care

Learn about MSK thoracic surgeon Valerie Rusch and her approach to treating people with lung cancer and other tumors of the chest.
MSK thoracic oncologist Kathryn Arbour, MD, seen smiling.
Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations

A heralded drug that experts hope will open a new era in treating pancreatic cancer is also showing early but strong signs it could be effective agains...
Dr. Gaetano Rocco is seen holding a component of the E-nose lung cancer test.
A Potential New Test for Lung Cancer: The Noninvasive E-Nose

Learn about a noninvasive lung cancer test called "E-nose" that is being investigated at Memorial Sloan Kettering.
Memorial Sloan Kettering thoracic surgeon Bernard Park looks at CT scans
Q&A
Should I Get Screened for Lung Cancer?

Find out how regular screenings with CT scans can help many people who smoke.
A computer screen displays four scans of lungs.
Lung Cancer Treatment Advances from MSK Presented at 2025 ASCO Meeting

New findings on several important lung cancer clinical trials were presented at the 2025 Annual Meeting of the American Society of Clinical Oncology.
Medical oncologist Alexander Drilon in a mask.
Taking Aim at Lung Cancer

For many people with lung cancer, targeted therapies can provide effective, long-term control of their disease with fewer side effects than chemotherapy.
Woman holding long-haired black cat.
Lung Cancer Caught Early: Marylou’s Story

A lifelong smoker overcomes discomfort over what a lung cancer imaging test might reveal. She hopes her experience helps reduce the stigma for others who smoke.
Memorial Sloan Kettering Cancer Center patient Sandra Lowe
Minimally Invasive Surgery for Lung Cancer Maximizes Recovery

Meet Sandra Lowe, who was diagnosed with lung cancer in February 2021 and was treated successfully at Memorial Sloan Kettering Cancer Center.
Dr. Alexander Drilon
Targeted Drug Selpercatinib Greatly Reduces Risk of Recurrence in Early-Stage Lung Cancer

A clinical trial led by an MSK researcher found that the targeted therapy selpercatinib reduces the risk of recurrence by more than 80% for patients with early-stage non-small cell lung cancers carrying a RET gene fusion.
Scientists Learn More about How Lung Cancer Becomes Resistant to Drugs

By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.